Award
National Institute of General Medical Sciences 2R44GM150317-02
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
Recipient
INTEGRAL MOLECULAR
Award Amount
$923,143.00
Ceiling
$923,143.00
Awarded
August 15, 2025
Identifier
2R44GM150317-02
Award for developing monoclonal antibodies targeting understudied membrane proteins, funded by NIH NIGMS, spanning 2023 to 2028.
Description
The project aims to develop high-quality monoclonal antibodies against understudied membrane proteins. The funding is provided by the NIH, specifically the NIGMS. The project duration is from May 1, 2023, to January 31, 2028.